Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACE vs TACE+RFA vs TACE+MWA for HCC
NCT02646137Phase 3Unknown
- Start
- Jan 2015
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 3, randomised trial (3 arms). Primary endpoint: Number of patients with successful ablation at 3 months. Status: unknown.
Beyond the preview
Go deeper on NCT02646137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646137.